Published 4 November 2009, doi:10.1136/bmj.b4506
Cite this as: BMJ 2009;339:b4506

News

Task force hopes to deliver affordable cancer drugs to developing countries

Zosia Kmietowicz

1 London

The first 150 words of the full text of this article appear below.

An international task force has been launched to expand the detection and treatment of cancer in less developed countries, where death rates from some cancers can be more than double those in richer nations.

A team of experts led by doctors from Harvard Medical School, Harvard School of Public Health, and the Dana-Farber Cancer Institute, hopes that the initiative will do for cancer patients what affordable drug pricing has achieved for people with HIV/AIDS, tuberculosis, polio, trachoma, and malaria in the developed world.

Felicia Knaul, head of the Harvard Global Equity Initiative, says that the task force will help to procure drugs for various cancers at affordable prices, expand the diagnosis and treatment of cancer, and improve survival.

Paul Farmer, from Harvard Medical School, who has been involved in building hospitals in developing countries, said, "Our experience has shown us that treatment and care for many types of cancers not . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Rapid Responses:

Read all Rapid Responses

Patient's consent
Dr.Firoz Ali M.D.,MRCP(UK)
bmj.com, 9 Nov 2009 [Full text]
Access jobs at BMJ Careers
Whats new online at Student BMJ